No pharmacokinetic studies have been performed in children.
In adults, the following PK parameters apply [SmPC Synapause]:
| Cmax: | 100 pg/ml (dose 0.5 mg) |
| Tmax: | 1-2 hours |
| T1/2: | 6-9 hours |
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Synechiae of the labia minora |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dose adjustment is not necessary in renal impairment (all grades).
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Labial pigmentation has been mentioned as possible side effect [Bussen 2016].
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Be aware of the possibility of overdosing: systemic absorption! Strictly as prescribed.
Experts say that the Synapause preparation is sometimes experienced by patients as being very painful.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Natural and semisynthetic estrogens, plain | ||
|---|---|---|
| G03CA01 | ||
| G03CA03 | ||
| G03CA57 | ||
| NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN | ||
|---|---|---|
| G03CA01 | ||
| G03CA03 | ||
| G03CA57 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.